Stigma: A Barrier Created by Limited Access to Care and Health Education on Hepatitis C (HCV) Testing and Treatment within the Puerto Rican Population.

Abstract

Hepatitis C (HCV) is a chronic disease that progresses slowly and has become increasingly prevalent in PWIDs residing in Puerto Rico. Limited access to healthcare and health information has contributed to the stigma surrounding HCV and persons who inject drugs (PWIDs). The systematic review aimed to understand how social determinants of health, limited access to care, HCV education, and stigma affect the overall health of individuals with HCV, especially at-risk populations of people who inject drugs (PWIDs) in Puerto Rico. The review emphasizes the importance of local and federal government agencies taking action to fund and develop HCV health programs for the public and healthcare providers. Rationale: Awareness and knowledge of HCV are crucial to reducing stigma and negative attitudes towards PWIDs in Puerto Rico. Educating people about HCV can reduce stigma and increase testing and treatment rates among PWIDs. Objective: This study investigates existing evidence-based information on the connection of stigma on Hepatitis C (HCV) negatively impacting testing and treatment in Puerto Rico among PWIDs and the need for government funding for prevention and treatment programs to address HCV stigma in Puerto Rico.